feed,title,long_url,short_url
SeekingAlpha,"Novartis acquires ocular gene therapy firm, Gyroscope Therapeutics for $1.5B",https://seekingalpha.com/news/3782555,
SeekingAlpha,SPYD: A Mediocre High-Yield Choice,https://seekingalpha.com/article/4476356,
